Extreme vulnerability of IDH1 mutant cancers to NAD+ depletion K Tateishi, H Wakimoto, AJ Iafrate, S Tanaka, F Loebel, N Lelic, ... Cancer cell 28 (6), 773-784, 2015 | 412 | 2015 |
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas H Wakimoto, S Tanaka, WT Curry, F Loebel, D Zhao, K Tateishi, J Chen, ... Clinical cancer research 20 (11), 2898-2909, 2014 | 195 | 2014 |
The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma T Zhang, Q Wang, D Zhao, Y Cui, B Cao, L Guo, SH Lu Clinical science 121 (10), 437-447, 2011 | 169 | 2011 |
FASL–844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer T Sun, Y Zhou, H Li, X Han, Y Shi, L Wang, X Miao, W Tan, D Zhao, ... The Journal of experimental medicine 202 (7), 967-974, 2005 | 139 | 2005 |
Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer B Zhang, T Sun, L Xue, X Han, B Zhang, N Lu, Y Shi, W Tan, Y Zhou, ... Carcinogenesis 28 (5), 1067-1073, 2006 | 126 | 2006 |
Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of … W Tan, J Wu, X Zhang, Y Guo, J Liu, T Sun, B Zhang, D Zhao, M Yang, ... Carcinogenesis 28 (6), 1197-1201, 2006 | 125 | 2006 |
Functional variants in cell death pathway genes and risk of pancreatic cancer M Yang, T Sun, L Wang, D Yu, X Zhang, X Miao, J Liu, D Zhao, H Li, ... Clinical Cancer Research 14 (10), 3230-3236, 2008 | 103 | 2008 |
Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer M Yang, Y Guo, X Zhang, X Miao, W Tan, T Sun, D Zhao, D Yu, J Liu, ... Carcinogenesis 28 (9), 1996-2001, 2007 | 83 | 2007 |
Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis D Yu, X Zhang, J Liu, P Yuan, W Tan, Y Guo, T Sun, D Zhao, M Yang, ... Clinical cancer research 14 (9), 2878-2886, 2008 | 82 | 2008 |
Role of CD14 promoter polymorphisms in Helicobacter pylori infection–related gastric carcinoma D Zhao, T Sun, X Zhang, Y Guo, D Yu, M Yang, W Tan, G Wang, D Lin Clinical cancer research 13 (8), 2362-2368, 2007 | 76 | 2007 |
Interaction of cyclooxygenase-2 variants and smoking in pancreatic cancer: a possible role of nucleophosmin D Zhao, D Xu, X Zhang, L Wang, W Tan, Y Guo, D Yu, H Li, P Zhao, D Lin Gastroenterology 136 (5), 1659-1668, 2009 | 68 | 2009 |
MicroRNA‐1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma T Zhang, D Zhao, Q Wang, X Yu, Y Cui, L Guo, SH Lu Molecular carcinogenesis 52 (8), 581-590, 2013 | 66 | 2013 |
Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms Y Guo, X Zhang, W Tan, X Miao, T Sun, D Zhao, D Lin Pharmacogenetics and genomics 17 (3), 197-205, 2007 | 61 | 2007 |
Progress and challenges in HER2-positive gastroesophageal adenocarcinoma D Zhao, SJ Klempner, J Chao Journal of Hematology & Oncology 12 (1), 50, 2019 | 58 | 2019 |
Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancer Y Guo, X Zhang, M Yang, X Miao, Y Shi, J Yao, W Tan, T Sun, D Zhao, ... Journal of medical genetics 47 (9), 616-622, 2010 | 55 | 2010 |
Haplotypes in matrix metalloproteinase gene cluster on chromosome 11q22 contribute to the risk of lung cancer development and progression T Sun, Y Gao, W Tan, S Ma, X Zhang, Y Wang, Q Zhang, Y Guo, D Zhao, ... Clinical cancer research 12 (23), 7009-7017, 2006 | 52 | 2006 |
Functional role of S100A14 genetic variants and their association with esophageal squamous cell carcinoma H Chen, D Yu, A Luo, W Tan, C Zhang, D Zhao, M Yang, J Liu, D Lin, ... Cancer research 69 (8), 3451-3457, 2009 | 48 | 2009 |
Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors VV Prabhu, AR Lulla, NS Madhukar, MD Ralff, D Zhao, CLB Kline, ... PloS one 12 (8), e0180541, 2017 | 40 | 2017 |
Association of the variable number of tandem repeats polymorphism in the promoter region of the SMYD3 gene with risk of esophageal squamous cell carcinoma in … H Wang, Y Liu, W Tan, Y Zhang, N Zhao, Y Jiang, C Lin, B Hao, D Zhao, ... Cancer science 99 (4), 787-791, 2008 | 33 | 2008 |
Genetic polymorphism in chemokine CCL22 and susceptibility to Helicobacter pylori infection‐related gastric carcinoma G Wang, D Yu, W Tan, D Zhao, C Wu, D Lin Cancer 115 (11), 2430-2437, 2009 | 31 | 2009 |